ICC International Cannabis’ corporate mandate is to plan, design, build and operate the highest quality, lowest cost Cannabis production, processing and distribution facilities worldwide. ICC boasts an in-depth understanding of both the Cannabis and biomedical industries, as well as world-class experience within the many associated Cannabis industry vehicles and derivatives. The Company is equipped with a suite of comprehensive solutions for emerging companies within the Cannabis industry. ICC’s robust service offering allows the Company to formulate key alliances and critical associations within a wide range of Cannabis verticals.
Via its diversified portfolio of companies and subsidiaries, ICC International Cannabis intends to further establish itself as a international Cannabis industry consolidation platform. The Company’s mission is to inspire holistic wellness by augmenting the design, development and production of the world’s most innovative and best performing Cannabis products and facilities.
In evaluating a prospective target business, ICC International Cannabis expects to conduct a thorough due diligence review which will encompass, among other things, meetings with incumbent management and employees, document reviews, and inspection of facilities, as well as a review of financial and other information which is made available to us.
Mr. David Shpilt boasts over four years of cannabis cultivation experience under Health Canada’s ACMPR (formerly MMPR) framework. David has worked directly with numerous master growers at commercially licensed producers, assisting to improve cultivation methodologies, as well as standardizing the cannabis cultivation to pharmaceutical standards. David is equipped with a robust network of international contacts within the cannabis industry and boasts a deep understanding of patient education and services.
Mr. Shpilt is a retired Board Certified Pedorthist and a Manual Osteopathic Practitioner, servicing tens of thousands of patients over the length of his career. Subsequently, David has owned and operated various healthcare centric enterprises, evolved in the supply of durable medical equipment, orthopaedic appliances and devices to both the Public and Private sectors. He successfully founded 12 clinics across Ontario over nine-year period, all of which continue to thrive to date.
Throughout his career, David has succeeded in congregating Physicians together with Complimentary and Alternative Practitioners within interdisciplinary settings, and most recently has stepped into functional medicine and clinical treatment offerings adjunctive to traditional frontline protocols. Mutually beneficial professional relationships with Physicians, coupled with a strong understanding of patient education and patient services, has made David a natural fit within the medical cannabis industry.
Mr. Beukman is the corporate counsel of the Pender group of companies, a position he has held since January, 1994. He graduated from Rand University of Johannesburg, South Africa, with a bachelor of law degree and a bachelor of law honours postgraduate degree in 1987. After practising as a lawyer, Mr. Beukman was employed as a legal adviser to the BHP Billiton group of companies. He has over 30 years of experience in the acquisition of assets and joint ventures. He is an advocate of the High Court of South Africa, and serves as chief executive officer and director on a number of TSX Venture Exchange-listed and Canadian Securities Exchange-listed companies.
CFO & Director
Mr. Nguyen is a chartered accountant and holds a degree from the University of British Columbia. He has held senior financial positions for both public and private companies where he provided assurance, corporate finance, tax and business advisory services.
Mr. Purdy is a practicing securities lawyer focused on technology, Cannabis and resource issuers. In his private practice, he has developed domestic and international experience with respect to public companies, reverse takeovers, mergers and acquisitions (M&A), and many facets fundamental to the Canadian capital markets. Prior to receiving his J.D. from the common-law section at the University of Ottawa, Mr. Purdy completed a bachelor of management and organizational studies degree from the University of Western Ontario, majoring in finance and administration. Mr. Purdy serves as a director of a number of CSE- and TSX Venture Exchange-listed companies.
Matthew Fish, B.A., J.D.
Mr. Fish is a practicing securities and corporate litigation lawyer focused on the technology and resource sectors. In his private practice, he has developed extensive experience with respect to public companies, capital markets, mergers and acquisitions and other facets fundamental to the natural resources, technology, and cannabis industries. Mr. Fish has served as director and officer of several publicly held companies and acts as director and general counsel for other privately held companies.
INTERNATIONAL CANNABIS CORP.
Suite 810 – 789 West Pender Street Vancouver, BC V6C 1H2
p: 604 687-2038